JOURNAL OF NEW CENTURY INNOVATIONS
Volume–76_Issue-1_May-2025
318
318
318
318
GLOMERULONEPHRITIS: HIDDEN POVERTY IN THE KIDNEYS
Abdurakhmonova Gulsanam Dilkashovna
Student of the Faculty of Second Medical Treatment,
Tashkent Medical Academy. Phone: 887310434
Scientific Advisor:
Tursunmetov Ibodulla
Department of Medical Biology and Histology,
Tashkent Medical Academy
Abstract:
Glomerulonephritis (GN) is a disease characterized by the
development of inflammatory processes in the renal glomeruli, which may lead to
kidney failure. This article reviews the main causes, clinical symptoms, diagnostic
methods, and treatment approaches for glomerulonephritis. The study analyzes the
prevalence and clinical features of both acute and chronic forms of glomerulonephritis.
It highlights the necessity for early detection of kidney diseases, the improvement of
treatment methods, and the development of holistic approaches in local medical
practice. Additionally, it was found that patients who frequently suffered from angina
and dental infections during childhood have a higher risk of developing kidney
diseases. The main goal is the early diagnosis of glomerulonephritis and the
development of treatment strategies adapted to local conditions.
Keywords:
Glomerulonephritis, proteinuria, chronic glomerulonephritis, angina,
diagnosis, treatment, abdominal pain, medicine.
Introduction
The kidneys are paired organs that perform vital physiological functions in the
human div. They are involved in processes such as blood purification, elimination of
toxins and excess fluids, and hormone production. In modern times, the rise in
unhealthy diets, stress, and bad habits has contributed to an increase in kidney diseases.
Glomerulonephritis is a condition in which the kidney glomeruli are damaged, although
other kidney structures (such as tubules and interstitial tissue) may also be affected in
some cases. It is classified into acute and chronic forms. Based on the mechanism of
development, glomerulonephritis is categorized as primary or secondary. It can lead to
kidney failure and is characterized by clinical symptoms such as the presence of blood
and protein in the urine, swelling (edema), and high blood pressure.
Glomerulonephritis, particularly in its chronic forms, damages the kidney’s main
filtration system and can significantly impact a patient’s overall health over time. This
article aims to analyze the causes, clinical symptoms, and treatment methods of
glomerulonephritis within the context of local healthcare conditions.
JOURNAL OF NEW CENTURY INNOVATIONS
Volume–76_Issue-1_May-2025
319
319
319
319
Figure 1.
Kidney undergoing transplantation
Methods
For the purpose of analysis in this article, existing scientific literature, including
clinical examinations, laboratory studies, and epidemiological data, were utilized. The
article reviews the types of glomerulonephritis, recommendations based on its causes,
clinical examinations and diagnostic methods, as well as modern treatment approaches.
The research primarily analyzes scientific articles and data presented by clinics
between 2015 and 2023.
Data Collection Methods:
Urine Tests: In the early stages of the disease, signs such as proteinuria (the
presence of protein in urine) and hematuria (blood in urine) were studied.
Blood Tests: Changes in creatinine and urea levels, as well as immunological
tests, were used to investigate the disease’s connection with the immune system.
Ultrasound Examinations: The ultrasound imaging of the kidneys and their
functional status were assessed to determine the severity and stage of the disease.
Figure 2.
Diseased kidney
JOURNAL OF NEW CENTURY INNOVATIONS
Volume–76_Issue-1_May-2025
320
320
320
320
Results
Glomerulonephritis (GN) is an inflammatory condition affecting the glomeruli of
the kidneys. Histologically, glomerulonephritis damages podocytes (cells that are part
of the kidney’s filtration structure) and the basement membrane within the glomeruli.
As a result of inflammation, immune complexes accumulate in the glomeruli, reducing
their filtration capacity. In GN, immunoglobulins and the complement system amplify
the inflammatory response, leading to microstructural changes within the glomeruli.
Physiologically, glomerulonephritis significantly impairs kidney function. The
disease reduces the filtration activity of the glomeruli, disrupting the kidneys’ primary
role in removing essential fluids, electrolytes, and waste products from the div.
Inflammation damages the filtration system of the glomeruli, allowing proteins to pass
into the urine (proteinuria). The severity of this condition varies depending on the
degree of inflammation, and in some cases, high levels of protein are observed in the
urine.
Common Causes Include:
Bacterial Infections:
Particularly streptococcal infections (e.g., “strep throat”)
can lead to glomerulonephritis.
Autoimmune Diseases:
Conditions such as lupus or Wegener’s granulomatosis
can damage the kidney glomeruli.
Viruses:
Hepatitis B and C, HIV, and Epstein-Barr virus may also contribute to
the development of glomerulonephritis.
1. Symptoms of the Disease
The
main
signs
and
symptoms
of
glomerulonephritis
include:
People who frequently experienced tonsillitis (throat infections) or dental pain during
childhood—especially those with chronic infections—may be more prone to kidney
diseases. These conditions can weaken the immune system, making the kidneys more
susceptible to inflammation. Specifically, infections such as tonsillitis can inflame the
glomeruli (small blood vessels in the kidneys), contributing to the development of
glomerulonephritis.
This chronic immune stimulation may lead to autoimmune responses, where the
div mistakenly produces antibodies against its own glomeruli (kidney capillaries).
This process can result in conditions such as post-streptococcal glomerulonephritis.
In Glomerulonephritis, swelling (edema) in the legs is frequently observed.
This is due to the kidneys’ reduced ability to excrete fluids and salts properly. As a
result, blood filtration and urine production are disrupted, leading to fluid buildup—
especially in the ankles and toes. Such symptoms are common in many kidney
disorders, and in the presence of inflammation, swelling may also appear in the face
and legs.
JOURNAL OF NEW CENTURY INNOVATIONS
Volume–76_Issue-1_May-2025
321
321
321
321
Chart 1.
Distribution of clinical symptoms of kidney diseases by age group
Stomach pain, particularly in chronic glomerulonephritis, can arise from changes
caused by impaired kidney function. These changes may disrupt the regulation of
stomach and intestinal activity, leading to gastrointestinal discomfort.
Foamy urine (proteinuria) is another common symptom of glomerulonephritis. It
indicates the passage of protein through the kidneys, signaling a loss of proper blood
and urine filtration. An increase in urea (creatinine and blood urea nitrogen) levels also
suggests decreased kidney function and accumulation of toxins in the div. These
changes may lead to symptoms such as memory decline, fatigue, and sleep
disturbances.
Obesity can be a risk factor for kidney disease. Excess weight and high blood
pressure put additional strain on the kidneys and can worsen related conditions.
However, some individuals may manage for a long time despite obesity, as their
immune system provides temporary support. Still, in the long term, obesity is likely to
exacerbate kidney disease.
Skin discoloration is another possible symptom of kidney disease. This is mainly
due to reduced kidney function and problems regulating div fluids. For example, the
skin on the face and hands may become dry or darkened.
Pale tongue—this symptom may appear in certain kidney diseases, especially in
cases of reduced kidney function or anemia. In the advanced stages of
glomerulonephritis, oxygen-carrying capacity declines, and a pale tongue may be
observed alongside other symptoms. However, this sign can also be associated with
other conditions.
As kidney disease progresses, the rise in urea and accumulation of toxins can
affect other div systems, including the nervous system. This may result in memory
0%
10%
20%
30%
40%
50%
60%
18–30 years
31–40 years
41–50 years
51+ years
Leg swelling (%)
Eye darkening (%)
Foamy urine (%)
JOURNAL OF NEW CENTURY INNOVATIONS
Volume–76_Issue-1_May-2025
322
322
322
322
loss, difficulty concentrating, and sleep disturbances.
2. Clinical Symptoms
Urinary Changes: The presence of blood and protein in the urine (hematuria and
proteinuria) is one of the primary indicators of the disease.
Edema (Swelling): Swelling in the face and legs occurs due to high blood pressure
and declining kidney function.
Painful Urination: Patients may experience discomfort and pain during urination.
High Blood Pressure: The chronic form of glomerulonephritis reduces the
kidneys’ ability to regulate blood pressure.
3. Diagnosis
Laboratory Tests: The presence of protein, blood, and other substances in the
urine is detected through analysis.
Blood Tests: Elevated levels of creatinine and urea are measured, along with
specific tests to evaluate immune function and metabolism.
Renal Ultrasound Imaging: Ultrasound scans help assess structural and functional
changes in kidneys affected by glomerulonephritis.
4. Treatment
Medications: Treatment involves the use of corticosteroids, immunosuppressants,
and antihypertensive drugs.
Dietary Therapy: A low-protein and low-sodium diet is essential in managing the
condition.
Dialysis: Dialysis is employed in cases where kidney function has severely
declined.
Corticosteroids and immunosuppressants have been used in the treatment of
glomerulonephritis. The treatment has shown effectiveness, although complete
recovery of kidney function is not guaranteed for all patients.
5. Local Analysis
The prevalence of acute glomerulonephritis was found to be high among certain
age groups in a specific region, particularly affecting men aged 25–40.
According to local epidemiological data, chronic glomerulonephritis has been
diagnosed in approximately 5% of the population, often associated with diabetes and
hypertension.
Kidney Function
Creatinine (mg/dL)
Urea (mg/dL)
Normal
0.6–1.2
15–20
Mild impairment
1.3–2.5
21–35
Moderate
impairment
2.6–4.5
36–60
Severe impairment
4.6+
60+
Table 1.
Decreased Kidney Function
JOURNAL OF NEW CENTURY INNOVATIONS
Volume–76_Issue-1_May-2025
323
323
323
323
Discussion
Glomerulonephritis is a complex disease, and its primary symptoms are not solely
dependent on kidney dysfunction. During the progression of the disease, symptoms
such as swelling in the legs, dark circles under the eyes, and changes in urine
composition (presence of protein and blood) are observed. Obese individuals may
sometimes be more resilient to glomerulonephritis due to a stronger immune system.
However, obesity can also impose additional strain on the kidneys, potentially
accelerating the development of the disease over time. All of these symptoms and risk
factors are important for early diagnosis and treatment of the disease. In the local
healthcare context, it is essential to conduct specialized training for healthcare workers
to ensure accurate and effective treatment of glomerulonephritis. Histological changes
in glomerulonephritis directly affect the clinical symptoms of the disease.
Inflammation of the glomeruli, fibrin accumulation, and tubular atrophy disrupt the
kidneys' normal filtration function.
After the age of 40, the likelihood of kidney disease may increase. As the div
ages, metabolic processes slow down, and the kidneys are affected by this process as
well. Additionally, high blood pressure, diabetes, and other metabolic diseases can lead
to kidney problems.
Risk of kidney disease in individuals born after 40:
Genetic Factors: Hereditary kidney diseases (such as polycystic kidney disease)
may be a significant risk factor for individuals of this age.
Metabolic Diseases: After the age of 40, the risk of metabolic disorders and
diabetes increases, which can lead to kidney disease.
Age Impact: As individuals age, the kidneys' filtration capacity decreases, which
may contribute to the development of kidney disease.
Conclusion
Glomerulonephritis is a serious condition caused by inflammation of the kidney
glomeruli. Early diagnosis and treatment are crucial to preserving kidney function. In
the local healthcare system, it is important to focus on early detection and the
application of modern treatment methods for glomerulonephritis. Expanding
preventive screenings and medical approaches is necessary. Additionally, new
treatment approaches should be developed to improve kidney health as individuals age.
In the future, efforts should be made to create public training programs, discussions,
and more medical screenings within the local population regarding kidney diseases.
References:
1.
Sherwood, L. (2015). Human Physiology: From Cells to Systems. Cengage
Learning.
JOURNAL OF NEW CENTURY INNOVATIONS
Volume–76_Issue-1_May-2025
324
324
324
324
2.
Junquiera, L. C., & Carneiro, J. (2013). Basic Histology: Text & Atlas. McGraw-
Hill.
3.
Taylor, P. D., & Robinson, K. (2020). The role of glomerulonephritis in kidney
failure. Journal of Nephrology Research, 5(2), 45-56.
4.
National
Kidney
Foundation.
(2023).
Glomerulonephritis.
https://www.kidney.org/atoz/content/glomerulonephritis
5.
Harris, J. (2021). Chronic kidney disease and its complications. HealthLine.
https://www.healthline.com/kidney-disease
6.
Med24.uz. Glomerulonephritis. https://med24.uz/uz/bolezn/glomerulonefrit
